Betamethasone valerate (aerosol)

Betamethasone valerate (aerosol)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Betamethasone valerate (aerosol) is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

• Betamethasone Valerate Foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.

Dosage

Note: For proper dispensing of foam, can must be inverted.

• For application to the scalp invert can and dispense a small amount of Betamethasone Valerate Foam, 0.12% onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.

• As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

• Betamethasone Valerate Foam, 0.12% should not be used with occlusive dressings unless directed by a physician.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Betamethasone valerate (aerosol) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Betamethasone valerate (aerosol) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1

• Dosing Information

• Dosage

There is limited information regarding FDA-Labeled Use of Betamethasone valerate (aerosol) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1

• Developed by:

• Class of Recommendation:

• Strength of Evidence:

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Betamethasone valerate (aerosol) in pediatric patients.

Non–Guideline-Supported Use

Condition1

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Betamethasone valerate (aerosol) in pediatric patients.

Contraindications

• Condition1

Warnings

• Description

Precautions

• Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Betamethasone valerate (aerosol) in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Betamethasone valerate (aerosol) in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Drug Interactions

• Drug

• Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

• Pregnancy Category

Pregnancy Category (AUS):

• Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Betamethasone valerate (aerosol) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Betamethasone valerate (aerosol) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Betamethasone valerate (aerosol) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Betamethasone valerate (aerosol) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Betamethasone valerate (aerosol) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Betamethasone valerate (aerosol) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Betamethasone valerate (aerosol) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Betamethasone valerate (aerosol) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Betamethasone valerate (aerosol) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Betamethasone valerate (aerosol) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Betamethasone valerate (aerosol) in patients who are immunocompromised.

Administration and Monitoring

Administration

• Oral

• Intravenous

Monitoring

There is limited information regarding Monitoring of Betamethasone valerate (aerosol) in the drug label.

• Description

IV Compatibility

There is limited information regarding IV Compatibility of Betamethasone valerate (aerosol) in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

• Description

Management

• Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Betamethasone valerate (aerosol) in the drug label.

Pharmacology

There is limited information regarding Betamethasone valerate (aerosol) Pharmacology in the drug label.

Mechanism of Action

Structure

File:Betamethasone valerate (aerosol)01.png

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Betamethasone valerate (aerosol) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Betamethasone valerate (aerosol) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Betamethasone valerate (aerosol) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Betamethasone valerate (aerosol) in the drug label.

How Supplied

Storage

There is limited information regarding Betamethasone valerate (aerosol) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Betamethasone valerate (aerosol) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Betamethasone valerate (aerosol) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Betamethasone valerate (aerosol) in the drug label.

Precautions with Alcohol

• Alcohol-Betamethasone valerate (aerosol) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

• BETAMETHASONE VALERATE®

Look-Alike Drug Names

• A® — B®

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

{{#subobject:

 |Page Name=Betamethasone valerate (aerosol)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Betamethasone valerate (aerosol)
 |Label Name=Betamethasone valerate (aerosol)11.png

}}

{{#subobject:

 |Label Page=Betamethasone valerate (aerosol)
 |Label Name=Betamethasone valerate (aerosol)11.png

}}